GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Gross-Profit-to-Asset %

Sopharma Trading AD (XBUL:SFT) Gross-Profit-to-Asset % : 28.69% (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sopharma Trading AD's annualized Gross Profit for the quarter that ended in Sep. 2023 was лв179 Mil. Sopharma Trading AD's average Total Assets over the quarter that ended in Sep. 2023 was лв623 Mil. Therefore, Sopharma Trading AD's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 28.69%.


Sopharma Trading AD Gross-Profit-to-Asset % Historical Data

The historical data trend for Sopharma Trading AD's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Gross-Profit-to-Asset % Chart

Sopharma Trading AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.09 17.76 18.96 23.55 28.89

Sopharma Trading AD Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.63 30.36 32.82 30.83 28.69

Competitive Comparison of Sopharma Trading AD's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Sopharma Trading AD's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Gross-Profit-to-Asset % falls into.



Sopharma Trading AD Gross-Profit-to-Asset % Calculation

Sopharma Trading AD's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=166.905/( (582.859+572.554)/ 2 )
=166.905/577.7065
=28.89 %

Sopharma Trading AD's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=178.712/( (617.041+628.685)/ 2 )
=178.712/622.863
=28.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sopharma Trading AD Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD (XBUL:SFT) Business Description

Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines